Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Evaluation of cancer therapy using diffusion magnetic resonance imaging.

Ross BD, Moffat BA, Lawrence TS, Mukherji SK, Gebarski SS, Quint DJ, Johnson TD, Junck L, Robertson PL, Muraszko KM, Dong Q, Meyer CR, Bland PH, McConville P, Geng H, Rehemtulla A, Chenevert TL.

Mol Cancer Ther. 2003 Jun;2(6):581-7. Review.

2.

Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy.

Chenevert TL, Meyer CR, Moffat BA, Rehemtulla A, Mukherji SK, Gebarski SS, Quint DJ, Robertson PL, Lawrence TS, Junck L, Taylor JM, Johnson TD, Dong Q, Muraszko KM, Brunberg JA, Ross BD.

Mol Imaging. 2002 Oct;1(4):336-43. Review.

PMID:
12926229
3.

Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors.

Chenevert TL, Stegman LD, Taylor JM, Robertson PL, Greenberg HS, Rehemtulla A, Ross BD.

J Natl Cancer Inst. 2000 Dec 20;92(24):2029-36.

4.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

5.

[New opportunities, MRI biomarkers in the evaluation of head and neck cancer].

Gődény M, Léránt G.

Magy Onkol. 2014 Dec;58(4):269-80. Epub 2014 Oct 8. Hungarian.

6.

Radiological evaluation of the therapeutic response of malignant diseases: status quo, innovative developments and requirements for radiology.

Höink AJ, Heindel W, Buerke B.

Rofo. 2014 Oct;186(10):927-36. doi: 10.1055/s-0034-1366741. Epub 2014 Aug 14. Review.

7.

Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker.

Hall DE, Moffat BA, Stojanovska J, Johnson TD, Li Z, Hamstra DA, Rehemtulla A, Chenevert TL, Carter J, Pietronigro D, Ross BD.

Clin Cancer Res. 2004 Dec 1;10(23):7852-9.

8.

Earlier detection of tumor treatment response using magnetic resonance diffusion imaging with oscillating gradients.

Colvin DC, Loveless ME, Does MD, Yue Z, Yankeelov TE, Gore JC.

Magn Reson Imaging. 2011 Apr;29(3):315-23. doi: 10.1016/j.mri.2010.10.003. Epub 2010 Dec 28.

9.
10.

Applications of magnetic resonance in model systems: cancer therapeutics.

Evelhoch JL, Gillies RJ, Karczmar GS, Koutcher JA, Maxwell RJ, Nalcioglu O, Raghunand N, Ronen SM, Ross BD, Swartz HM.

Neoplasia. 2000 Jan-Apr;2(1-2):152-65. Review.

11.

The role of magnetic resonance imaging biomarkers in clinical trials of treatment response in cancer.

Yankeelov TE, Arlinghaus LR, Li X, Gore JC.

Semin Oncol. 2011 Feb;38(1):16-25. doi: 10.1053/j.seminoncol.2010.11.007. Review.

12.

Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study.

Røe K, Kakar M, Seierstad T, Ree AH, Olsen DR.

Radiat Oncol. 2011 Jun 8;6:65. doi: 10.1186/1748-717X-6-65.

13.

Cancer imaging: novel concepts in clinical magnetic resonance imaging.

Kwee TC, Takahara T, Klomp DW, Luijten PR.

J Intern Med. 2010 Aug;268(2):120-32. doi: 10.1111/j.1365-2796.2010.02243.x. Epub 2010 Apr 23. Review.

14.

Diffusion-weighted MRI for assessment of early cancer treatment response.

Galbán S, Brisset JC, Rehemtulla A, Chenevert TL, Ross BD, Galbán CJ.

Curr Pharm Biotechnol. 2010 Sep 1;11(6):701-8. Review.

15.

Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy.

Rehemtulla A, Hall DE, Stegman LD, Prasad U, Chen G, Bhojani MS, Chenevert TL, Ross BD.

Mol Imaging. 2002 Jan-Mar;1(1):43-55.

PMID:
12920860
16.

Effect of vascular targeting agent in rat tumor model: dynamic contrast-enhanced versus diffusion-weighted MR imaging.

Thoeny HC, De Keyzer F, Vandecaveye V, Chen F, Sun X, Bosmans H, Hermans R, Verbeken EK, Boesch C, Marchal G, Landuyt W, Ni Y.

Radiology. 2005 Nov;237(2):492-9. Epub 2005 Sep 28.

PMID:
16192323
17.

Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.

Moffat BA, Chenevert TL, Lawrence TS, Meyer CR, Johnson TD, Dong Q, Tsien C, Mukherji S, Quint DJ, Gebarski SS, Robertson PL, Junck LR, Rehemtulla A, Ross BD.

Proc Natl Acad Sci U S A. 2005 Apr 12;102(15):5524-9. Epub 2005 Apr 1.

18.

Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring.

Su MY, Yu H, Chiou JY, Wang J, Nalcioglu O, Fruehauf JP, Mehta RS, Baick CH.

Technol Cancer Res Treat. 2002 Dec;1(6):479-88.

PMID:
12625775
19.

New insights into tumor microstructure using temporal diffusion spectroscopy.

Colvin DC, Yankeelov TE, Does MD, Yue Z, Quarles C, Gore JC.

Cancer Res. 2008 Jul 15;68(14):5941-7. doi: 10.1158/0008-5472.CAN-08-0832.

20.

Diffusion-weighted and Gd-EOB-DTPA-contrast-enhanced magnetic resonance imaging for characterization of tumor necrosis in an animal model.

Vossen JA, Buijs M, Geschwind JF, Liapi E, Prieto Ventura V, Lee KH, Bluemke DA, Kamel IR.

J Comput Assist Tomogr. 2009 Jul-Aug;33(4):626-30. doi: 10.1097/RCT.0b013e3181953df3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk